Scilex Holding Co Return Tang Equity
Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
- Scilex Holding Co return tang equity for the quarter ending 2026-06-30 was 121.75%, a 341.89% increase year-over-year.
- Scilex Holding Co return tang equity for the quarter ending 2026-03-31 was 120.24%, a 313.80% increase year-over-year.
- Scilex Holding Co return tang equity for the quarter ending 2025-12-31 was 131.56%, a 331.10% increase year-over-year.
- Scilex Holding Co return tang equity for the quarter ending 2025-09-30 was 149.54%, a 340.12% increase year-over-year.
- Scilex Holding Co return tang equity for fiscal 2025 was 131.56%, a 331.10% increase from fiscal 2024.
- Scilex Holding Co return tang equity for fiscal 2024 was 30.52%, a 40.50% decline from fiscal 2023.
- Scilex Holding Co return tang equity for fiscal 2023 was 51.29%, a 60.85% decline from fiscal 2022.
- Scilex Holding Co return tang equity for fiscal 2022 was 131.02%, a 309.18% increase from fiscal 2021.
- Available history
- 2020-12-31 to 2026-06-30
- Data captured
Historical Return Tang Equity
Annual Return Tang Equity
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |